{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:45:32Z","timestamp":1769107532970,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["340-2013-5187"],"award-info":[{"award-number":["340-2013-5187"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["521-2013-4236"],"award-info":[{"award-number":["521-2013-4236"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish state under the agreement concerning research and education of doctors","award":["ALFGBG-427301"],"award-info":[{"award-number":["ALFGBG-427301"]}]},{"name":"Swedish state under the agreement concerning research and education of doctors","award":["ALFGBG-136761"],"award-info":[{"award-number":["ALFGBG-136761"]}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20110155"],"award-info":[{"award-number":["20110155"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2015-0438"],"award-info":[{"award-number":["2015-0438"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","award":["GLS-331961"],"award-info":[{"award-number":["GLS-331961"]}],"id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00228-018-2574-6","type":"journal-article","created":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T22:27:22Z","timestamp":1539556042000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Decrease in loop diuretic treatment from 2005 to 2014 in Swedish real-life patients with chronic heart failure"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-0499","authenticated-orcid":false,"given":"P\u00e4r","family":"Par\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Zverkova Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"issue":"12","key":"2574_CR1","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27(12):1431\u20131439","journal-title":"Eur Heart J"},{"issue":"8","key":"2574_CR2","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1253\/circj.CJ-11-1196","volume":"76","author":"S Hamaguchi","year":"2012","unstructured":"Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, The JCARE-CARD Investigators (2012) Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 76(8):1920\u20131927","journal-title":"Circ J"},{"issue":"7","key":"2574_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ijcp.12144","volume":"67","author":"FL Dini","year":"2013","unstructured":"Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L, Genta FT, Cicoira M, Tavazzi L, Temporelli PL (2013) Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract 67(7):656\u2013664","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2574_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0167-5273(99)00129-1","volume":"71","author":"KJ Harjai","year":"1999","unstructured":"Harjai KJ, Dinshaw HK, Nunez E, Shah M, Thompson H, Turgut T, Ventura HO (1999) The prognostic implications of outpatient diuretic dose in heart failure. Int J Cardiol 71(3):219\u2013225","journal-title":"Int J Cardiol"},{"issue":"12","key":"2574_CR5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","volume":"97","author":"S Eshaghian","year":"2006","unstructured":"Eshaghian S, Horwich TB, Fonarow GC (2006) Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97(12):1759\u20131764","journal-title":"Am J Cardiol"},{"issue":"5","key":"2574_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/oxfordjournals.eurheartj.a015339","volume":"18","author":"Task Force of the Working Group on Heart Failure of the European Society of Cardiology","year":"1997","unstructured":"Task Force of the Working Group on Heart Failure of the European Society of Cardiology (1997) The treatment of heart failure. Eur Heart J 18(5):736\u2013753","journal-title":"Eur Heart J"},{"issue":"17","key":"2574_CR7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","volume":"22","author":"WJ Remme","year":"2001","unstructured":"Remme WJ, Swedberg K (2001) Task Force for the D, Treatment of Chronic Heart Failure ESoC. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22(17):1527\u20131560","journal-title":"Eur Heart J"},{"issue":"11","key":"2574_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"K Swedberg","year":"2005","unstructured":"Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, L\u00e9vy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pi\u00e9rard L, Remme WJ, Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26(11):1115\u20131140","journal-title":"Eur Heart J"},{"issue":"19","key":"2574_CR9","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Str\u00f6mberg A, van Veldhuisen D, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388\u20132442","journal-title":"Eur Heart J"},{"issue":"14","key":"2574_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787\u20131847","journal-title":"Eur Heart J"},{"issue":"27","key":"2574_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"issue":"3","key":"2574_CR12","first-page":"194","volume":"5","author":"SW Joffe","year":"2013","unstructured":"Joffe SW, Dewolf M, Shih J, McManus DD, Spencer FA, Lessard D, Gore JM, Goldberg RJ (2013) Trends in the medical management of patients with heart failure. J Clin Med Res 5(3):194\u2013204","journal-title":"J Clin Med Res"},{"issue":"5","key":"2574_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/eurjhf\/hfq228","volume":"13","author":"OR Peuter de","year":"2011","unstructured":"de Peuter OR, Lip GY, Souverein PC, Klungel OH, de Boer A, Buller HR et al (2011) Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. Eur J Heart Fail 13(5):489\u2013495","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2574_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ahj.2004.04.002","volume":"148","author":"NL Smith","year":"2004","unstructured":"Smith NL, Chan JD, Rea TD, Wiggins KL, Gottdiener JS, Lumley T, Psaty BM (2004) Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure. Am Heart J 148(4):710\u2013717","journal-title":"Am Heart J"},{"issue":"3","key":"2574_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCHEARTFAILURE.112.000178","volume":"6","author":"JC Loh","year":"2013","unstructured":"Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, Moriguchi J, Hamilton MA, Tseng CH, Fonarow GC, Horwich TB (2013) Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail 6(3):411\u2013419","journal-title":"Circ Heart Fail"},{"issue":"9","key":"2574_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.amjmed.2003.11.025","volume":"116","author":"DS Lee","year":"2004","unstructured":"Lee DS, Mamdani MM, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV (2004) Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med 116(9):581\u2013589","journal-title":"Am J Med"},{"issue":"5","key":"2574_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ejhf.496","volume":"18","author":"T Thorvaldsen","year":"2016","unstructured":"Thorvaldsen T, Benson L, Dahlstrom U, Edner M, Lund LH (2016) Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012. Eur J Heart Fail 18(5):503\u2013511","journal-title":"Eur J Heart Fail"},{"key":"2574_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450","journal-title":"BMC Public Health"},{"issue":"5","key":"2574_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ejheart.2004.12.007","volume":"7","author":"E Ingelsson","year":"2005","unstructured":"Ingelsson E, Arnlov J, Sundstrom J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7(5):787\u2013791","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"2574_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U et al (2007) The new Swedish prescribed drug register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726\u2013735","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"2574_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ejhf.762","volume":"19","author":"LH Lund","year":"2017","unstructured":"Lund LH, Carrero JJ, Farahmand B, Henriksson KM, Jonsson A, Jernberg T, Dahlstr\u00f6m U (2017) Association between enrolment in a heart failure quality registry and subsequent mortality\u2014a nationwide cohort study. Eur J Heart Fail 19(9):1107\u20131116","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2574_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G (2017 Dec) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19(12):1574\u20131585","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"2574_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/eurjhf\/hfr070","volume":"13","author":"JM Testani","year":"2011","unstructured":"Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE (2011) Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail 13(8):877\u2013884","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2574_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/eurjhf\/hfs209","volume":"15","author":"M Dupont","year":"2013","unstructured":"Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WH (2013) Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail 15(4):433\u2013440","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2574_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/hrt.57.1.17","volume":"57","author":"J Bayliss","year":"1987","unstructured":"Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57(1):17\u201322","journal-title":"Br Heart J"},{"issue":"12","key":"2574_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","volume":"100","author":"HA Cooper","year":"1999","unstructured":"Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100(12):1311\u20131315","journal-title":"Circulation"},{"issue":"1","key":"2574_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","volume":"2","author":"GM Felker","year":"2009","unstructured":"Felker GM, O\u2019Connor CM, Braunwald E (2009) Heart Failure Clinical Research Network I. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2(1):56\u201362","journal-title":"Circ Heart Fail"},{"issue":"13","key":"2574_CR28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.116.025941","volume":"135","author":"MN Christiansen","year":"2017","unstructured":"Christiansen MN, Kober L, Weeke P, Vasan RS, Jeppesen JL, Smith JG et al (2017) Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 135(13):1214\u20131223","journal-title":"Circulation"},{"issue":"6","key":"2574_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","volume":"175","author":"Y Gerber","year":"2015","unstructured":"Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL (2015) A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175(6):996\u20131004","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2574_CR30","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1136\/hrt.2006.099523","volume":"94","author":"MJ Lenzen","year":"2008","unstructured":"Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML et al (2008) Management of patients with heart failure in clinical practice: differences between men and women. Heart 94(3):e10","journal-title":"Heart"},{"issue":"1","key":"2574_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jech-2015-205738","volume":"70","author":"A Ohlsson","year":"2016","unstructured":"Ohlsson A, Lindahl B, Hanning M, Westerling R (2016) Inequity of access to ACE inhibitors in Swedish heart failure patients: a register-based study. J Epidemiol Community Health 70(1):97\u2013103","journal-title":"J Epidemiol Community Health"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2574-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T19:05:17Z","timestamp":1571079917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2574-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2574"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2574-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Regional Ethical Review Board of the University of Gothenburg (540\u201311, T063\u201313).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Par\u00e9n has served on the speakers\u2019 bureau or received consulting fees from Servier, Novartis, and Boehringer Ingelheim. Dr. Schaufelberger has received research grants from her institution, served on the speakers\u2019 bureau, or received consulting fees from Pfizer, Bayer AG, and Novartis. All other authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}